(PRWEB) May 22, 2012
Lonza will offer a live Webinar featuring the latest software advancements of MODA™—a paperless quality control (QC) microbiology solution for the life sciences industry—on Tuesday, June 12, 2012 at 8:00 AM EST (International) and 1:00 PM EST (U.S.). Each session is 60 minutes and includes Q&A.
Sinéad Cowman, a Lonza Informatics expert and product strategist, will present how the MODA™ solution serves as a regulatory compliant platform for managing and reporting tests of surfaces, air, personnel, water, compressed gas, and products.
Webinar will feature:
To register for the International event, visit http://register.webcastgroup.com/L4/?wid=0557335973
To register for the U.S. event, visit http://register.webcastgroup.com/L4/?wid=0557335974
Within the Life Sciences industry, paper-based QC micro laboratory processes can be expensive, error-prone, time and labor-intensive. With the MODA™ solution, organizations can automate quality control processes for regulated manufacturing and quickly advance their Green initiatives. By combining automated scheduling, workflows, mobile data acquisition, device integration, and advanced analytics, the MODA™ solution delivers efficiencies across your organization. Gain insight into your manufacturing operations and quickly access reports and trends on your quality data—all at the click of a button.
About MODA™ Solution
More science. Less paper.™ The MODA™ solution strengthens Lonza’s overall informatics platform by adding a complementary product offering for quality assurance (QA) and quality control (QC) organizations in the life science industry. The MODA™ solution offers automated data collection, workflow management, on demand analytics and visualization of regulated manufacturing processes, including environmental monitoring (EM), utility testing, and product testing. The MODA™ solution eliminates inefficiencies and reduces error rates inherent with paper-based systems. Further information can be found at http://www.lonza.com/moda
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers’ needs from research to final product manufacture. It is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2010, the company had sales of CHF 2.680 billion. Further information can be found at http://www.lonza.com